- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07603388
Effects of Pelvic Floor Rehab Protocol on Urinary Incontinence
17 de julho de 2026 atualizado por: Riphah International University
Effects of Pregnancy Specific Pelvic Floor Rehab Protocol on Urinary Incontinence
Urinary incontinence is a serious health issue that deeply affects a person's daily life and overall well-being.
The global prevalence of UI is between 5 to 69% during a woman's lifetime, with higher prevalence in older age groups.
The goal of this randomized controlled trial is to compare the effects of pregnancy specific pelvic floor rehab protocol with the standard protocol on urinary incontinence.
Participants will be randomly assigned to one of the two groups.
The results of this trial would be helpful in this way that how Pregnancy specific pelvic floor rehab protocol can provide support for pregnant ladies with urinary incontinence and improve health outcomes.
Visão geral do estudo
Status
Ativo, não recrutando
Condições
Descrição detalhada
The International Continence Society defines urinary incontinence as the 'unintentional or involuntary leakage of urine'.
Urinary incontinence is a serious health issue that deeply affects a person's daily life and overall well-being.
It can be physically exhausting and emotionally overwhelming, often leading to embarrassment, loss of confidence, and feelings of helplessness.
Many people dealing with it also struggle with anxiety and depression, as it limits their freedom and makes even simple daily tasks feel challenging.
Urinary incontinence (UI) is common during pregnancy with prevalence rates of 31% in nulliparous women and 42% in parous women.
The global prevalence of UI is between 5 to 69% during a woman's lifetime, with higher prevalence in older age groups. .
Urinary incontinence during pregnancy affects women's physical comfort, emotional well-being, and quality of life, yet it remains under-identified and undertreated in standard antenatal care.
Although pelvic floor exercises are widely recommended, most existing programs are not adapted to the unique demands of pregnancy.
A structured, pregnancy-specific pelvic floor rehabilitation protocol can address these needs more effectively by offering trimester-based guidance, functional training, and education. .
This pregnancy-specific pelvic floor rehabilitation protocol follows a progressive 4-week plan focused on pelvic floor muscle training, core activation, and functional strengthening.
Exercises such as Kegels, abdominal drawing-in, bridging, and clamshells are performed in various positions with controlled breathing.
Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education.
Participants will be randomly assigned through convenient sampling method to each groups.
Ethical considerations will be completely taken and data will be analyzed through SPSS version 26.
This study aims to evaluate the impact of such a protocol and provide evidence to support its integration into routine prenatal care, potentially improving maternal outcomes and long-term recovery.
Tipo de estudo
Intervencional
Inscrição (Estimado)
48
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Islamabad
-
Islamabad, Islamabad, Paquistão, 44000
- Riphah International Hospital
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Pregnant women aged 18-35 yrs.
- Score ≥1 on stress or urge subscale of the Questionnaire for Incontinence Diagnosis
- No participation in a structured pelvic floor rehabilitation program within the last six months.
Exclusion Criteria:
• Patients with High-risk pregnancy.
- Known neurological disorders.
- History of pelvic surgery.
- ACOG Contraindications for Exercise
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Standard Pelvic floor Rehab Protocol Group
This group receives standard protocol for strengthening of pelvic floor to prevent urinary incontinence.
|
in this group, standard exercises used for strengthening of pelvic floor to prevent urinary incontinence will be implemented.
|
|
Experimental: Pregnancy Specific Pelvic floor Rehab Protocol (PSPFR) Group (2nd Trimester)
This group will receive a pregnancy-specific supervised pelvic floor rehabilitation protocol and basic antenatal education.
There will be 2 sessions per week for 4 weeks.
Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education.
|
This pregnancy-specific pelvic floor rehabilitation protocol follows a progressive 4-week plan focused on pelvic floor muscle training, core activation, and functional strengthening.
Exercises such as Kegels, abdominal drawing-in, bridging, and clamshells are performed in various positions with controlled breathing.
Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education.
The instructions of the supervised exercises would be Hold for 2 s in 3 repetitions, 5 seconds rest, 1 minute of rest between each exercise & 2 sets each.
The record of each session will be written in diaries.
|
|
Experimental: Pregnancy Specific Pelvic floor Rehab Protocol (PSPFR) Group (3rd Trimester)
This group will receive a pregnancy-specific supervised pelvic floor rehabilitation protocol and basic antenatal education.
There will be 2 sessions per week for 4 weeks.
Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education.
|
This pregnancy-specific pelvic floor rehabilitation protocol follows a progressive 4-week plan focused on pelvic floor muscle training, core activation, and functional strengthening.
Exercises such as Kegels, abdominal drawing-in, bridging, and clamshells are performed in various positions with controlled breathing.
Each 30-minute session, conducted twice weekly, includes a structured warm-up, weekly targeted exercises (Week 1-4), and a cool-down phase for relaxation, flexibility, and bladder/postural education.
The instructions of the supervised exercises would be Hold for 2 s in 3 repetitions, 5 seconds rest, 1 minute of rest between each exercise & 2 sets each.
The record of each session will be written in diaries.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Questionnaire for Incontinence Diagnosis
Prazo: 4 weeks
|
The Questionnaire for Incontinence Diagnosis is a self-reported screening tool used to identify the presence and type of urinary incontinence, such as stress, urge, or mixed incontinence.
It consists of structured questions related to symptom triggers, frequency, and leakage patterns.
Each item scores 0 (None of the time), 1 (Rarely), 2 (Once in a while), 3 (Often), 4 (Most of the time) or 5 (All of the time).
Responses to items 1, 2 and 3 are summed for the Stress score; and responses to items 4, 5, and 6 are summed for the Urge score.
|
4 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incontinence Severity Index
Prazo: 4 weeks
|
The ISI is a quick, two-question tool that assesses the frequency and amount of urine leakage.
Scores range from 0 to 12, indicating severity from none to very severe.
It is simple to administer and useful for tracking symptom changes over time.
|
4 weeks
|
|
International Consultation on Incontinence Questionnaire (ICIQ-UI-SF)
Prazo: 4 weeks
|
The ICIQ-UI-SF is a validated self-reported questionnaire that assesses the frequency, severity, and impact of urinary incontinence.
Scores range from 0 to 21, with higher scores indicating greater symptom severity and quality-of-life impact.
It is widely used to quantify the patient-reported burden of incontinence.
|
4 weeks
|
|
Incontinence Impact Questionnaire
Prazo: 4 weeks
|
The IIQ-7 assesses the psychosocial and functional impact of urinary incontinence on daily life, including physical activity, travel, and emotional well-being.
Scores range from 0 to 100, with higher scores reflecting a greater negative impact.
It is a useful tool for evaluating quality of life related to incontinence.
|
4 weeks
|
|
Patient Global Impression of Improvement Scale
Prazo: 4 weeks
|
The PGI-I is a single-item scale that captures the patient's overall perception of symptom improvement after treatment.
It reflects subjective satisfaction with the intervention.
The 7-point scale ranges from 1 (very much better) to 7 (very much worse), with lower scores indicating greater improvement.
|
4 weeks
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Dr Zahra Ijaz, Riphah International University
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Publicações Gerais
- Wu Y, Li T, Cai F, Ye X, Xu M. Stable pelvic floor muscle training improves urinary incontinence in women with gestational diabetes mellitus. J Obstet Gynaecol. 2024 Dec;44(1):2420192. doi: 10.1080/01443615.2024.2420192. Epub 2024 Oct 30.
- Kamali S, Ozengin N, Topcuoglu MA. The effect of e-pelvic floor muscle training on symptoms in women with stress urinary incontinence: a randomized controlled trial. Women Health. 2023 Jul 3;63(6):473-483. doi: 10.1080/03630242.2023.2223729. Epub 2023 Jun 14.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
1 de novembro de 2025
Conclusão Primária (Real)
7 de maio de 2026
Conclusão do estudo (Estimado)
30 de julho de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
18 de maio de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
18 de maio de 2026
Primeira postagem (Real)
22 de maio de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
20 de julho de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
17 de julho de 2026
Última verificação
1 de julho de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças urogenitais
- Doenças Urogenitais Masculinas
- Doenças Urológicas
- Doenças Urogenitais Femininas
- Doenças urogenitais femininas e complicações na gravidez
- Distúrbios da micção
- Sintomas do Trato Urinário Inferior
- Manifestações Urológicas
- Condições Patológicas, Sinais e Sintomas
- Sinais e sintomas
- Incontinencia urinaria
- Características da população
- Demografia
- Grupos populacionais
Outros números de identificação do estudo
- Attiya Azhar
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .